We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.9B
AUM Growth
-$428M
(-2.8%)
Cap. Flow
-$938M
Cap. Flow
% of AUM
-6.29%
Top 10 Holdings %
Top 10 Hldgs %
21.36%
Holding
1,841
New
125
Increased
760
Reduced
901
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$15M |
| 2 |
Franklin Resources
BEN
|
+$13M |
| 3 |
Clorox
CLX
|
+$9.09M |
| 4 |
Lowe's Companies
LOW
|
+$9.01M |
| 5 |
Kimberly-Clark
KMB
|
+$7.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$84.7M |
| 2 |
Amazon
AMZN
|
+$51.3M |
| 3 |
Microsoft
MSFT
|
+$51.2M |
| 4 |
Meta Platforms (Facebook)
META
|
+$26.2M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$23.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.18% |
| 2 | Financials | 13.19% |
| 3 | Healthcare | 12.85% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Communication Services | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Dana Inc
DAN
$2.91B
| $653K | ﹤0.01% |
32,328
+684
| +2% | +$16.3K |
|
1002
Theravance Biopharma
TBPH
$874M
| $651K | ﹤0.01% |
28,696
-1,860
| -6% | -$44.2K |
|
|
EFOR
1003
Everforth Inc
EFOR
$845M
| $647K | ﹤0.01% |
8,273
+357
| +5% | +$29.2K |
|
1004
Avanos Medical
AVNS
$1.17B
| $647K | ﹤0.01% |
11,299
+156
| +1% | +$8.24K |
|
1005
Dycom Industries
DY
$12.9B
| $646K | ﹤0.01% |
6,838
+145
| +2% | +$14.8K |
|
|
CVSA
1006
Covista Inc
CVSA
$3.94B
| $645K | ﹤0.01% |
13,415
+279
| +2% | +$13.3K |
|
|
ARRS
1007
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $645K | ﹤0.01% |
26,395
+1,923
| +8% | +$50.6K |
|
|
TSE
1008
DELISTED
Trinseo
TSE
| $644K | ﹤0.01% |
9,079
-84
| -0.9% | -$6.25K |
|
|
NUVA
1009
DELISTED
NuVasive, Inc.
NUVA
| $644K | ﹤0.01% |
12,360
+231
| +2% | +$12.1K |
|
1010
Bio-Rad Laboratories Class A
BIO
$8.42B
| $639K | ﹤0.01% |
2,216
-14
| -0.6% | -$3.87K |
|
1011
Alcoa
AA
$11.7B
| $637K | ﹤0.01% |
13,580
-362
| -3% | -$18.2K |
|
1012
Bankunited
BKU
$3.38B
| $633K | ﹤0.01% |
15,500
-182
| -1% | -$7.54K |
|
|
HRC
1013
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $632K | ﹤0.01% |
7,239
-56
| -0.8% | -$4.98K |
|
|
PPLI
1014
People Inc
PPLI
$3.1B
| $629K | ﹤0.01% |
23,092
+3,055
| +15% | +$83.7K |
|
|
WPG
1015
DELISTED
Washington Prime Group Inc.
WPG
| $628K | ﹤0.01% |
8,603
-1,162
| -12% | -$75K |
|
1016
Four Corners Property Trust
FCPT
$2.86B
| $627K | ﹤0.01% |
25,438
-151
| -0.6% | -$3.46K |
|
1017
Cabot Corp
CBT
$4.65B
| $622K | ﹤0.01% |
10,069
-111
| -1% | -$6.57K |
|
1018
Iovance Biotherapeutics
IOVA
$2.23B
| $621K | ﹤0.01% |
48,497
-1,443
| -3% | -$21.1K |
|
1019
Boyd Gaming
BYD
$6.47B
| $619K | ﹤0.01% |
17,846
+294
| +2% | +$10.3K |
|
1020
Targa Resources
TRGP
$60.4B
| $616K | ﹤0.01% |
12,445
-9,768
| -44% | -$464K |
|
1021
Arrow Electronics
ARW
$10.9B
| $615K | ﹤0.01% |
8,164
+57
| +0.7% | +$4.34K |
|
1022
Intellia Therapeutics
NTLA
$1.5B
| $615K | ﹤0.01% |
22,483
+779
| +4% | +$18.9K |
|
|
BBBY
1023
DELISTED
Bed Bath & Beyond Inc
BBBY
| $613K | ﹤0.01% |
30,768
+17,745
| +136% | +$331K |
|
1024
First Solar
FSLR
$21.8B
| $611K | ﹤0.01% |
11,596
-727
| -6% | -$47.6K |
|
|
CTLT
1025
DELISTED
CATALENT, INC.
CTLT
| $610K | ﹤0.01% |
14,572
-17,234
| -54% | -$696K |
|
Similar funds
ProShare Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, ProShare Advisors held 1,841 positions worth $14.9B, down 2.8% from $15.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors withdrew a net $938M in Q2 2018, closing 50 positions and reducing 901 holdings. Its most notable exit was Monsanto Co, an estimated $11.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, ProShare Advisors opened a new position in First of Long Island Corp worth $6.18M.
- ProShare Advisors's largest Q2 2018 buy was First of Long Island Corp: 248,853 shares worth $6.18M.
- ProShare Advisors added most to Walgreens Boots Alliance in Q2 2018, an estimated $15M increase.
- ProShare Advisors's biggest Q2 2018 reduction was Apple, cutting an estimated $84.7M.
- ProShare Advisors fully exited Monsanto Co in Q2 2018, selling an estimated $11.2M.
- ProShare Advisors's ten largest holdings make up 21% of its $14.9B portfolio in Q2 2018.
- ProShare Advisors opened 125 new positions and closed 50 in Q2 2018.
- ProShare Advisors's portfolio value fell 2.8% quarter-over-quarter to $14.9B.
Based on ProShare Advisors's 13F filing for Q2 2018, filed 13 Aug 2018.